Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBlackbird PLC Regulatory News (BIRD)

Share Price Information for Blackbird PLC (BIRD)

Share Price is delayed by 15 minutes
Get Live Data
1.80    0.00 (0.00%)
Bid:
1.60
Ask:
2.00
Spread: 0.40 (25.00%)
Market Cap: £8.64m
BIRD Live PriceLast checked at - London Stock Exchange

Intraday Blackbird PLC Share Chart

Loan Facility - Correction

5 Jun 2007 18:22

Forbidden Technologies PLC05 June 2007 5 June 2007 Forbidden Technologies plc £1 million Loan Facility - Correction The following announcement replaces the announcement regarding the £1 millionloan facility released today at 16.49pm under RNS number 8296X. It includes acorrection to the date after which time a rate of interest payable of 10% willstart accruing, from 30 November 2007 to 30 November 2008. There is also anadditional final paragraph. Further to the announcement by Forbidden Technologies plc (the "Company") of 22May 2007 in which it was noted that the Directors were considering a number ofpotential sources of funding including a possible director's loan, the Companyannounces that it has signed an agreement to secure unsecured loan facilitiesfrom its Chairman (Vic Steel) and CEO (Stephen Streater) of up to £1,000,000(one million pounds). In the event of a new share issue of £1,000,000 or more,the loan advanced by the Chairman of up to £100,000 would, at the option of theChairman, be convertible into shares on the same terms as the share issue. The loan is expected to provide working capital for the company for theforeseeable future, and to support the company to a break even or profitableposition, and as such the maximum facilities available for drawdown each monthare tapered over the next three years. No interest will accrue on the facilities until 30 November 2008 at which pointthe rate of interest payable will increase to 10% per annum for the twelve monthperiod to 30 November 2009 and by a further by 10% per annum until the loanfacilities are repaid in full. The facilities (or any part thereof) may berepaid at any time by the Company and will become immediately repayable ondemand upon the occurrence of standard events of default. Forbidden Technologies plc (the "Company") confirms that the IndependentDirectors (being the Board of Directors excluding Messrs Steel and Streater)consider, having consulted with its Nominated Adviser, that the terms of thetransaction outlined therein are fair and reasonable insofar as the shareholdersof the Company are concerned. Enquiries:Forbidden Technologies plc 020 8879 7245 Stephen Streater, Chief Executive Nominated Adviser - Bell Lawrie (a division of Brewin DolphinSecurities Limited) 0141 221 7733 Alan Stewart College Hill 020 7457 2020 Corinna Dorward/Adrian Duffield This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
15th May 20267:00 amRNSelevate.io update, notice of AGM, accounts posting
8th Apr 20269:13 amRNS-Relevate.io integrated Epidemic Sound music library
25th Mar 20267:00 amRNSDirector/PDMR Shareholding
23rd Mar 20267:00 amRNSFinal Results
16th Feb 20267:00 amRNSNotice of Results and Investor Presentation
2nd Feb 20267:00 amRNS-Relevate.io launches new structured pricing tiers
30th Jan 20265:00 pmRNSTotal Voting Rights
28th Jan 20267:00 amRNS-Relevate.io teams up with NatWest Accelerator
23rd Jan 20267:00 amRNS-Relevate.io releases subtitles and transcriptions
19th Jan 20265:58 pmRNSHolding(s) in Company
7th Jan 20267:00 amRNS-Relevate.io partners with Epidemic Sound
31st Dec 202512:30 pmRNSBlock admission six monthly return
31st Dec 202512:30 pmRNSBlock admission six monthly return
18th Dec 20257:00 amRNSSubscription to raise £500,000
11th Nov 20257:00 amRNSBill Roberts joins as an adviser to the Board
5th Nov 20257:00 amRNS-Relevate.io expands AI capabilities and adds tokens
29th Sep 20257:00 amRNSInterim Results
26th Sep 20257:00 amRNS-Relevate.io partners with NY Chamber of Commerce
24th Sep 20258:45 amRNSHolding(s) in Company
11th Sep 202512:00 pmRNSChange of website
10th Sep 20257:00 amRNS-Relevate.io attends Ideas Fest
3rd Sep 20257:00 amRNS-Relevate.io partners with Enterprise Nation
27th Aug 20257:00 amRNSNotice of Interim Results & Investor Presentation
18th Aug 20257:00 amRNS-Relevate.io collaboration with Barclays Eagle Labs
12th Aug 20257:00 amRNSGrant of share options
7th Aug 20257:00 amRNS-RContract Win
31st Jul 20255:00 pmRNSTotal Voting Rights
28th Jul 20252:19 pmRNSHolding(s) in Company
25th Jul 20257:00 amRNS-RFurther product development of elevate.io
24th Jul 202511:16 amRNSResult of General Meeting and Total Voting Rights
9th Jul 20253:01 pmRNSHolding(s) in Company
7th Jul 20259:49 amRNSResult of Retail Offer and Notice of GM
3rd Jul 20257:05 amRNSRetail Offer to raise up to £200,000
3rd Jul 20257:00 amRNSPlacing and Subscription to raise £2.0 million
30th Jun 20255:37 pmRNSBlock admission six monthly return
18th Jun 20255:10 pmRNSResult of AGM
18th Jun 20257:00 amRNSAGM Statement
14th May 20257:00 amRNSNotice of AGM and posting of Annual Report
12th May 20257:00 amRNSelevate.io update
24th Apr 20253:44 pmRNSHolding(s) in Company
24th Apr 20257:00 amRNSBoard Change
4th Mar 20257:00 amRNSFinal Results
13th Feb 20257:00 amRNSNotice of Results and Investor Presentation
10th Feb 20257:00 amRNSelevate.io launches Creator payment plan
6th Feb 202512:50 pmRNSHolding(s) in Company
27th Jan 20257:00 amRNSLisher joins elevate.io GTM implementation
31st Dec 202412:30 pmRNSBlock admission six monthly return
31st Dec 20247:00 amRNSPricing of LTIP units
19th Dec 20247:00 amRNSProduct and deal renewals update
20th Nov 20247:00 amRNSelevate.io soars to 40,000 users

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.